Impulse Oscillometry for Leukotriene D 4 Inhalation Challenge in Asthma
Authors:
Open Access
- 28 May 2013
- journal article
- Published by SAGE Publications in Respiratory Care
- Vol. 58 (12) , 2120-2126
Abstract
BACKGROUND: The value of impulse oscillometry (IOS) for bronchial provocation testing is poorly defined. We investigated the positive threshold derived from the parameters and diagnostic power of IOS for asthma with the leukotriene D 4 bronchial provocation test. METHODS: We enrolled 62 subjects with asthma and 21 healthy subjects. IOS was employed to perform the leukotriene D 4 bronchial provocation test, followed by spirometry. The positive threshold was determined based on the cutoff point in the receiver operating characteristic curve, from which the parameters with the highest diagnostic power were obtained. RESULTS: Airway impedance at 5 Hz (Z 5 ), resistance at 5 Hz (R 5 ), and resonance frequency had the highest diagnostic power (areas under curve 0.82, 0.82, and 0.81, respectively), with increases of 57%, 43%, and 63%, corresponding to a 20% decrease in FEV 1 , respectively. IOS indices yielded assay sensitivity and specificity similar to that of spirometry. The positive threshold for IOS, defined as either a 57% increase in Z 5 or a 63% increase in resonance frequency in the bronchial provocation test, yielded an assay accuracy of 0.6 in subjects with asthma. CONCLUSIONS: IOS during the leukotriene D 4 bronchial provocation test has a diagnostic power similar to that of spirometry. Either a 57% increase in Z 5 or a 63% increase in resonance frequency may be regarded as a surrogate of FEV 1 decrease to determine airway hyper-responsiveness in asthma.Keywords
This publication has 28 references indexed in Scilit:
- Leukotriene E4: Perspective on the forgotten mediatorJournal of Allergy and Clinical Immunology, 2009
- The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma—A comparison with leukotriene D4 induced broncoconstrictionPulmonary Pharmacology & Therapeutics, 2008
- The Anti-inflammatory Effects of Leukotriene-Modifying Drugs and Their Use in AsthmaChest, 2001
- Exhaled Nitric Oxide following Leukotriene E4 and Methacholine Inhalation in Patients with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Effect of Inhaled Leukotriene D4 on Airway Eosinophilia and Airway Hyperresponsiveness in Asthmatic SubjectsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Leukotrienes as Mediators of Airway ObstructionAmerican Journal of Respiratory and Critical Care Medicine, 1998
- A Single Dose of Zafirlukast Reduces LTD4-Induced Bronchoconstriction in Patients on Maintenance Inhaled Corticosteroid TherapyAnnals of Allergy, Asthma & Immunology, 1998
- Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteersThorax, 1997
- Leukotrienes in the Pathogenesis of AsthmaChest, 1997
- The reproducibility and effect on non‐specific airway responsiveness of inhaled prostaglandin D2 and leukotriene D4 in asthmatic subjects.British Journal of Clinical Pharmacology, 1995